.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Farmers Insurance
Cantor Fitzgerald
Chubb
Argus Health
AstraZeneca
Colorcon
Accenture
Cerilliant
Fuji

Generated: September 19, 2017

DrugPatentWatch Database Preview

Organon Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?

ORGANON USA INC has thirty-four approved drugs.

There are seven US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.

There are one hundred and fifty-seven patent family members on ORGANON USA INC drugs in forty countries.

Summary for Applicant: Organon Usa Inc

Patents:7
Tradenames:34
Ingredients:29
NDAs:34
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
ZEMURON
rocuronium bromide
INJECTABLE;INJECTION020214-002Mar 17, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021211-003Feb 11, 2004DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Organon Usa Inc
PAVULON
pancuronium bromide
INJECTABLE;INJECTION017015-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
MAXIBOLIN
ethylestrenol
TABLET;ORAL014005-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
LIQUAEMIN SODIUM
heparin sodium
INJECTABLE;INJECTION000552-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021211-004Feb 11, 2005RXYesYes► Subscribe► SubscribeY ► Subscribe
Organon Usa Inc
LIQUAEMIN SODIUM PRESERVATIVE FREE
heparin sodium
INJECTABLE;INJECTION000552-011Apr 11, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-001Sep 29, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
RAPLON
rapacuronium bromide
INJECTABLE;INJECTION020984-002Aug 18, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-002Sep 29, 1997► Subscribe► Subscribe
Organon Usa Inc
REMERON
mirtazapine
TABLET;ORAL020415-003Mar 17, 1997► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021211-004Feb 11, 2005► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-001Sep 29, 1997► Subscribe► Subscribe
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 1999► Subscribe► Subscribe
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 1999► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021273-001Aug 26, 2005► Subscribe► Subscribe
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
Organon Usa Inc
CALDEROL
calcifediol
CAPSULE;ORAL018312-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-001Jan 12, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ORGANON USA INC drugs

Drugname Dosage Strength Tradename Submissiondate
ethinyl estradiol and etonogestrel
Vaginal Ring0.015 mg/24 hour and 0.12 mg/24 hour
NUVARING
6/17/2013
ganirelix acetate
Injection250 mcg/0.5 mL, 1 mL PFS
GANIRELIX ACETATE
3/30/2012

International Patent Family for Organon Usa Inc Drugs

Country Document Number Estimated Expiration
Hong Kong1114800► Subscribe
Australia736339► Subscribe
China1953770► Subscribe
Norway20073749► Subscribe
European Patent Office1188444► Subscribe
Luxembourg91655► Subscribe
Austria237348► Subscribe
Argentina020618► Subscribe
Malaysia135913► Subscribe
Poland190103► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Organon Usa Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00221Netherlands► SubscribePRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
2010 00022Denmark► Subscribe
C/GB00/024United Kingdom► SubscribePRODUCT NAME: GANIRELIX OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/130/001 20000517; UK EU/1/00/130/002 20000517
C/GB10/022United Kingdom► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125
00440Netherlands► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125; FORMER OWNER: N.V. ORGANON, NL
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
2009 00017Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
C0024France► SubscribePRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C0010Belgium► SubscribePRODUCT NAME: FOLLITROPINE ALPHA; NAT. REGISTRATION NO/DATE: EU1/95/001/001 19951020; FIRST REGISTRATION: FI 11529 19940815
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Express Scripts
Farmers Insurance
UBS
QuintilesIMS
Dow
Deloitte
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot